Biological markers as prognostic and clinical evaluation tools.
D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000378:metabolism / Q000517:prevention & control* / Q000628:therapy; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000378:metabolism; D008403:Mass Screening; D009362:Neoplasm Metastasis; D011379:Prognosis; D012306:Risk
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D003404:Creatinine; D006909:Hydroxyproline